Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Infliximab-induced scleredema in a patient with rheumatoid arthritis
Prabha Ranganathan
Division of Rheumatology
Institute of Clinical and Translational Sciences (ICTS)
Division of Veterans Affairs
Rheumatic Diseases Research Resource-Based Center
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Infliximab-induced scleredema in a patient with rheumatoid arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rheumatoid Arthritis
100%
Infliximab
100%
Scleredema
100%
Tumor Necrosis Factor-α
50%
Induration
37%
Etanercept
25%
Tumor Growth Factor
25%
Chimeric Antibody
25%
Older Patients
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Viral Infection
12%
High Titer
12%
Bacterial Infection
12%
Recurring
12%
Blocking Agent
12%
Collagen Synthesis
12%
Collagen Deposition
12%
Rechallenge
12%
Laboratory Evaluation
12%
Monoclonal Gammopathy
12%
Offending
12%
Factor Interaction
12%
Immunology and Microbiology
Inflammatory Arthritis
100%
Infliximab
100%
Tumor Necrosis Factor
50%
Etanercept
25%
Cancer Growth Factor
25%
Cytokine
12%
Titer
12%
Viral Disease
12%
Collagen Synthesis
12%
Monoclonal Immunoglobulinemia
12%